RISE-Vac—Co-Production of Vaccine Education Materials with Persons Living in Prison

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Increasing vaccination knowledge is effective in addressing hesitancy and is particularly important in populations deprived of liberty who may not routinely have access to health information, ensuring health equity. RISE-Vac is a European Union–funded project aiming to promote vaccine literacy, offer, and uptake in prisons in Europe. We consulted persons living in prisons in the United Kingdom (through the Prisoner Policy Network), France, and Moldova to determine their vaccination knowledge gaps, the information they would like to receive, and how they would like to receive it. We received 344 responses: 224 from the United Kingdom, 70 from France, and 50 from Moldova. Participants were particularly interested in learning about the effectiveness, side effects, and manufacturing of vaccines. Their responses guided the development of educational materials, including a brochure that will be piloted in prisons in Europe. Persons with experience of imprisonment were involved at every stage of this project.

Related collections

Most cited references 11

Record: found
Abstract: not found
Article: not found

Using thematic analysis in psychology

Virginia Braun, Victoria Clarke (2014)

0 comments Cited 17541 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.

Kate Dolan, Andrea L Wirtz, Babak Moazen … (2016)

The prison setting presents not only challenges, but also opportunities, for the prevention and treatment of HIV, viral hepatitis, and tuberculosis. We did a comprehensive literature search of data published between 2005 and 2015 to understand the global epidemiology of HIV, hepatitis C virus (HCV), hepatitis B virus (HBV), and tuberculosis in prisoners. We further modelled the contribution of imprisonment and the potential impact of prevention interventions on HIV transmission in this population. Of the estimated 10·2 million people incarcerated worldwide on any given day in 2014, we estimated that 3·8% have HIV (389 000 living with HIV), 15·1% have HCV (1 546 500), 4·8% have chronic HBV (491 500), and 2·8% have active tuberculosis (286 000). The few studies on incidence suggest that intraprison transmission is generally low, except for large-scale outbreaks. Our model indicates that decreasing the incarceration rate in people who inject drugs and providing opioid agonist therapy could reduce the burden of HIV in this population. The prevalence of HIV, HCV, HBV, and tuberculosis is higher in prison populations than in the general population, mainly because of the criminalisation of drug use and the detention of people who use drugs. The most effective way of controlling these infections in prisoners and the broader community is to reduce the incarceration of people who inject drugs.

0 comments Cited 146 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Substance Use and HIV Among Female Sex Workers and Female Prisoners: Risk Environments and Implications for Prevention, Treatment, and Policies.

Steffanie Strathdee, Brooke West, Elizabeth Reed … (2015)

Female sex workers (FSWs) and female prisoners experience elevated HIV prevalence relative to the general population because of unprotected sex and unsafe drug use practices, but the antecedents of these behaviors are often structural in nature. We review the literature on HIV risk environments for FSWs and female prisoners, highlighting similarities and differences in the physical, social, economic, and policy/legal environments that need to be understood to optimize HIV prevention, treatment, and policy responses. Sex work venues, mobility, gender norms, stigma, debt, and the laws and policies governing sex work are important influences in the HIV risk environment among FSWs, affecting their exposure to violence and ability to practice safer sex and safer drug use behaviors. Female prisoners are much more likely to have a drug problem than do male prisoners and have higher HIV prevalence, yet are much less likely to have access to HIV prevention and treatment and access to drug treatment in prison. Women who trade sex or are imprisoned and engage in substance use should not be considered in separate silos because sex workers have high rates of incarceration and many female prisoners have a history of sex work. Repeated cycles of arrest, incarceration, and release can be socially and economically destabilizing for women, exacerbating their HIV risk. This dynamic interplay requires a multisectoral approach to HIV prevention and treatment that appreciates and respects that not all women are willing, able, or want to stop sex work or drug use. Women who engage in sex work, use drugs, or are imprisoned come from all communities and deserve sustained access to HIV prevention and treatment for substance use and HIV, helping them and their families to lead healthy and satisfying lives.

0 comments Cited 31 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Journal

Journal ID (nlm-ta): Emerg Infect Dis

Journal ID (iso-abbrev): Emerg Infect Dis

Journal ID (publisher-id): EID

Title: Emerging Infectious Diseases

Publisher: Centers for Disease Control and Prevention

ISSN (Print): 1080-6040

ISSN (Electronic): 1080-6059

Publication date (Print): April 2024

Volume: 30

Issue: Suppl 1

Pages: S56-S61

Affiliations

[1]Prison Reform Trust, London, UK (F. Laryea-Adekimi, P. Harriott);

[2]United Kingdom Health Security Agency, London (J. D’Arcy, E. Plugge, A. Roselló);

[3]University of Pisa, Pisa, Italy (A. Bardelli, L. Tavoschi);

[4]Centre Pénitentiaire, Villeneuve-lès-Maguelone, France (A. Mieuset);

[5]National Administration of Penitentiaries, Chișinău, Moldova (V. Busmachiu, I. Barbiros);

[6]University Hospital of Montpellier, Montpellier, France (F. Meroueh);

[7]State University of Medicine and Pharmacy “Nicolae Testemiţanu,” Chișinău (S. Doltu);

[8]Pathways Centre, Dublin, Ireland (N. Walsh);

[9]University of Southampton, Southampton, UK (E. Plugge)

Author notes

Address for correspondence: Femi Laryea-Adekimi, Prison Reform Trust, 15 Northburgh St, London, EC1V 0JR, UK; email: femi@ 123456prisonreformtrust.org.uk

Article

Publisher ID: 23-0812

DOI: 10.3201/eid3013.230812

PMC ID: 10986827

PubMed ID: 38561865

SO-VID: bdf621e9-b4e5-4745-83f9-f13dbab28124

License:

Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.

RISE-Vac—Co-Production of Vaccine Education Materials with Persons Living in Prison

Read this article at

Abstract

Related collections

Annual Reviews Societal Impact of the Covid-19 Pandemic

Most cited references 11

Using thematic analysis in psychology

Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.

Substance Use and HIV Among Female Sex Workers and Female Prisoners: Risk Environments and Implications for Prevention, Treatment, and Policies.

Author and article information

Journal

Affiliations

Author notes

Article

History

Categories

Comments

Comment on this article

Similar content 180

Most referenced authors 190